Proposed ‘preclinical obesity’ diagnosis ignites global debate

Love it or hate it, BMI is back in the news. But that's just the starting point in a debate over how to define obesity. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

April 2, 2026 Check out STAT+

Sponsored By

STAT Madness is down to the final four! Cast your vote now in our bracket-style contest to find this year's best innovation in science and medicine.

Mario Tama/Getty Images STAT+ | Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts Large companies that increased U.S. production and countries that have struck trade deals won't be subject to the tariffs Trump dangled to encourage compliance. By Daniel Payne STAT+ | Proposed 'preclinical obesity' diagnosis ignites global debate among experts A new way to define obesity aims to sharpen the diagnosis. Critics warn it could delay care, exclude diabetes, and deepen inequities in accessing treatment. By Elizabeth Cooney STAT+ | Beyond detection: In the age of clinical AI, what counts as an FDA 'breakthrough' medical device? An analysis of AI-powered medical devices, deemed 'breakthroughs' by the FDA, shows that the agency seems to be prioritizing big-picture, multi-problem solutions. By Katie Palmer STAT reporter goes up against radiologists to spot deepfake X-rays Radiologists could spot AI deepfakes only 75% of the time in a recent study. STAT reporter Katie Palmer tries the same test in this week STATus Report. By Alex Hogan STAT+ | Small drugmakers, facing threat of tariffs, negotiate pricing deals with White House Administration officials are seeking to replicate the strategy used with larger companies in bid to lower prices. By Daniel Payne STAT+ | Opinion: Cardiology's finally prioritizing prevention — but what will it look like? At 2026's biggest gathering of cardiologists, prevention was the buzzword — but it remains unclear how to actually deliver this care to people. By Vishal Khetpal Sean Gallup/Getty Images Opinion: Medical misinformation wins when patients can't see their doctors Desperate patients, unable to get timely doctors' appointments, seek help wherever they can find it. By Ilana Yurkiewicz STAT+ | 'Takeover Tuesday' saves biotech's quarter In this week's edition of "Adam's Biotech Scorecard," Adam also has a preview of Cytokinetics' ACACIA heart study and some thoughts on Biogen. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser